Biomerica Inc SEC filings BMRA
Biomerica Inc has 605 filings in SEC EDGAR's recent list, going back to Sep 28, 1995. Its latest annual report, Form 10-K, was filed on Aug 31, 2026 for the period ended May 31, 2026. The latest quarterly report (Form 10-Q) was filed on Oct 15, 2026, covering the quarter ended Aug 31, 2026. The most recent current report (Form 8-K) was filed on Oct 15, 2026 (officer or director change). The company's fiscal year ends on May 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change
|
Oct 15, 2026 | Oct 9, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Aug 26, 2026 | Aug 20, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Jun 4, 2026 | May 29, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Dec 16, 2025 | Dec 12, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 8, 2025 | Oct 7, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jun 6, 2025 | Jun 4, 2025 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Apr 16, 2025 | Apr 15, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Dec 17, 2024 | Dec 13, 2024 |
| 8-K |
Current report
Listing notice
|
Nov 6, 2024 | Nov 6, 2024 |
| 8-K |
Current report
Officer or director change
|
Jun 28, 2024 | Jun 26, 2024 |
| 8-K |
Current report
Material agreement, Listing notice
|
May 10, 2024 | May 7, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Dec 11, 2023 | Dec 7, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 19, 2023 | Sep 15, 2023 |
| 8-K |
Current report
Officer or director change
|
Aug 28, 2023 | Aug 28, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jul 26, 2023 | Jul 24, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 25, 2023 | Apr 25, 2023 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Mar 7, 2023 | Mar 3, 2023 |
| 8-K |
Current report
Officer or director change
|
Mar 2, 2023 | Mar 1, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 7, 2023 | Feb 7, 2023 |
| 8-K/A |
Amended current report
Shareholder vote results
|
Dec 29, 2022 | Dec 7, 2022 |
| 8-K |
Current report
Officer or director change
|
Dec 16, 2022 | Dec 16, 2022 |
| 8-K |
Current report
Officer or director change
|
Dec 16, 2022 | Dec 12, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Dec 9, 2022 | Dec 7, 2022 |
| 8-K |
Current report
Officer or director change
|
Dec 9, 2022 | Dec 7, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 14, 2022 | Nov 14, 2022 |
| 8-K |
Current report
Auditor change
|
Apr 19, 2022 | Apr 19, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 10, 2022 | Feb 8, 2022 |
| 8-K |
Current report
Results of operations, Other events
|
Dec 16, 2021 | Dec 16, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Dec 10, 2021 | Dec 9, 2021 |
| 8-K |
Current report
Other events
|
Dec 7, 2021 | Dec 2, 2021 |
| 8-K |
Current report
Restatement
|
Sep 30, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 25, 2021 | Jun 24, 2021 |
| 8-K |
Current report
Other events
|
Jan 22, 2021 | Jan 22, 2021 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 14, 2021 | Jan 12, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Dec 11, 2020 | Dec 11, 2020 |
| 8-K |
Current report
Officer or director change
|
Dec 11, 2020 | Dec 11, 2020 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure, Other events
|
Sep 2, 2020 | Aug 27, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 2, 2020 | Sep 1, 2020 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 29, 2020 | Jun 29, 2020 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 17, 2020 | Jun 16, 2020 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 2, 2020 | Jun 1, 2020 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 11, 2020 | May 7, 2020 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Apr 6, 2020 | Apr 1, 2020 |
| 8-K |
Current report
Other events
|
Mar 20, 2020 | Mar 20, 2020 |
| 8-K |
Current report
Other events
|
Mar 18, 2020 | Mar 17, 2020 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Feb 27, 2020 | Feb 21, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 9, 2020 | Jan 9, 2020 |
| 8-K |
Current report
Shareholder vote results
|
Dec 13, 2019 | Dec 11, 2019 |
| 8-K |
Current report
Other events
|
Sep 4, 2019 | Sep 4, 2019 |
| 8-K |
Current report
Other events
|
Jun 5, 2019 | May 31, 2019 |
| 8-K |
Current report
Other events
|
Apr 9, 2019 | Apr 5, 2019 |
| 8-K |
Current report
Officer or director change
|
Mar 21, 2019 | Mar 21, 2019 |
| 8-K |
Current report
Shareholder vote results
|
Dec 14, 2018 | Dec 13, 2018 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 28, 2018 | Sep 27, 2018 |
| 8-K |
Current report
Other events
|
Aug 27, 2018 | Aug 22, 2018 |
| 8-K |
Current report
Other events
|
Mar 8, 2018 | Dec 1, 2017 |
| 8-K |
Current report
Shareholder vote results
|
Jan 10, 2018 | Dec 13, 2017 |
| 8-K |
Current report
Material agreement
|
Dec 4, 2017 | Dec 1, 2017 |
| 8-K |
Current report
Other events
|
Sep 12, 2016 | Sep 12, 2016 |
| 8-K |
Current report
Other events
|
Aug 10, 2016 | Aug 10, 2016 |
| 8-K |
Current report
Officer or director change
|
Jul 18, 2016 | Jul 14, 2016 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
May 26, 2016 | May 25, 2016 |
| 8-K |
Current report
Other events
|
Mar 16, 2016 | Mar 15, 2016 |
| 8-K |
Current report
Unregistered share sale
|
Apr 15, 2013 | Apr 8, 2013 |
| 8-K |
Current report
Material agreement, Agreement ended
|
Apr 8, 2013 | Apr 2, 2013 |
| 8-K |
Current report
Other events
|
May 29, 2008 | May 27, 2008 |
| 8-K |
Current report
Officer or director change
|
Jul 16, 2007 | Jul 16, 2007 |
| 8-K |
Current report
Other events
|
Jun 19, 2007 | Jun 6, 2007 |
| 8-K |
Current report
Other events
|
May 3, 2007 | May 2, 2007 |
| 8-K |
Current report
Officer or director change
|
May 1, 2007 | May 1, 2007 |
| 8-K |
Current report
Other events
|
Apr 14, 2006 | Apr 14, 2006 |
| 8-K |
Current report
Other events
|
Dec 5, 2005 | Dec 1, 2005 |
| 8-K |
Current report
Material agreement
|
Nov 24, 2004 | Nov 19, 2004 |
| 8-K |
Current report
Officer or director change
|
Sep 24, 2004 | Sep 21, 2004 |
| 8-K/A | Amended current report | Jun 8, 2004 | Jun 7, 2004 |
| 8-K | Current report | Jun 3, 2004 | Jun 2, 2004 |
| 8-K | Current report | Jun 6, 2002 | May 30, 2002 |
| 8-K | Current report | Jul 7, 1999 | Jul 7, 1999 |
| 8-K | Current report | May 13, 1997 | Apr 28, 1997 |
Showing 79 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- In Vitro & In Vivo Diagnostic Substances (SIC 2835)
- Listed as
- BMRA (Nasdaq)
- Fiscal year ends
- May 31
- Incorporated in
- DE
- Headquarters
- Irvine, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 73290
Other In Vitro & In Vivo Diagnostic Substances companies
- Idexx Laboratories Inc /DE IDXX
- Lantheus Holdings, Inc. LNTH
- Neogen Corp NEOG
- Celldex Therapeutics, Inc. CLDX
- Intellia Therapeutics, Inc. NTLA
- QuidelOrtho Corp QDEL
- Achieve Life Sciences, Inc. ACHV
- Myriad Genetics Inc MYGN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.